Literature DB >> 8166655

The role of protein phosphorylation and cytoskeletal reorganization in microparticle formation from the platelet plasma membrane.

Y Yano1, J Kambayashi, E Shiba, M Sakon, E Oiki, K Fukuda, T Kawasaki, T Mori.   

Abstract

Platelets activated by various agonists produce vesicles (microparticles; MPs) from the plasma membrane. However, the mechanism of this MP formation remains to be elucidated. To investigate the possible involvement of protein phosphorylation and cytoskeletal reorganization in MP formation, the effects of various inhibitors on MP formation were investigated. Flow cytometry was employed to detect the amount of MP formation by using monoclonal antibodies against glycoprotein (GP) IIb-IIIa (NNKY 1-32) or GPIIb (Tab). The relationship between changes in cytoskeletal architecture and MP formation in the platelets activated by thrombin plus collagen was observed by scanning electron microscopy (SEM). MPs were observed in the vicinity of the terminals of pseudopods, suggesting that MPs may be related by budding of the pseudopods. Cytochalasin D (10 microM) inhibited MP formation from the activated platelets almost completely. Moreover, SEM of the cytochalasin D-treated platelets revealed the absence of shape change, pseudopod formation and MPs. These findings suggest that cytoskeletal reorganization is necessary for MP formation. Since cytoskeletal reorganization is considered to be regulated by a dynamic phosphorylation-dephosphorylation process, we investigated the effects of the protein phosphatase inhibitors, calyculin A (CLA) and okadaic acid (OA), on MP formation. Flow cytometry showed that these two inhibitors doubled MP formation in activated platelets. SEM of the platelets treated with CLA or OA demonstrated more prominent shape change and pseudopod formation in these platelets than in those without inhibitor. From these results, we conclude that cytoskeletal reorganization, which is controlled by phosphorylation, is involved in MP formation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8166655      PMCID: PMC1138055          DOI: 10.1042/bj2990303

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Talin is phosphorylated on tyrosine in chicken embryo fibroblasts transformed by Rous sarcoma virus.

Authors:  E B Pasquale; P A Maher; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

2.  Repolarization of the membrane potential of blood platelets after complement damage: evidence for a Ca++ -dependent exocytotic elimination of C5b-9 pores.

Authors:  P J Sims; T Wiedmer
Journal:  Blood       Date:  1986-08       Impact factor: 22.113

3.  Cytochalasin D inhibits actin polymerization and induces depolymerization of actin filaments formed during platelet shape change.

Authors:  J F Casella; M D Flanagan; S Lin
Journal:  Nature       Date:  1981-09-24       Impact factor: 49.962

4.  Role of actin binding protein phosphorylation in platelet cytoskeleton assembly.

Authors:  Q Q Zhuang; S Rosenberg; J Lawrence; A Stracher
Journal:  Biochem Biophys Res Commun       Date:  1984-01-30       Impact factor: 3.575

5.  Inhibition of actin polymerization in blood platelets by cytochalasins.

Authors:  J E Fox; D R Phillips
Journal:  Nature       Date:  1981-08-13       Impact factor: 49.962

6.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

7.  The demarcation membrane system of the megakaryocyte: a misnomer?

Authors:  J M Radley; C J Haller
Journal:  Blood       Date:  1982-07       Impact factor: 22.113

8.  The effects of calpeptin (a calpain specific inhibitor) on agonist induced microparticle formation from the platelet plasma membrane.

Authors:  Y Yano; E Shiba; J Kambayashi; M Sakon; T Kawasaki; K Fujitani; J Kang; T Mori
Journal:  Thromb Res       Date:  1993-09-01       Impact factor: 3.944

9.  Isolation and quantitation of the platelet membrane glycoprotein deficient in thrombasthenia using a monoclonal hybridoma antibody.

Authors:  R P McEver; N L Baenziger; P W Majerus
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

10.  Identification of two structurally and functionally distinct sites on human platelet membrane glycoprotein IIb-IIIa using monoclonal antibodies.

Authors:  R P McEver; E M Bennett; M N Martin
Journal:  J Biol Chem       Date:  1983-04-25       Impact factor: 5.157

View more
  15 in total

Review 1.  Function and clinical significance of platelet-derived microparticles.

Authors:  S Nomura
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

2.  Platelet microparticles and platelet adhesion: therapeutic implications for the prevention and treatment of stroke.

Authors:  Kiat T Tan; Gregory Y H Lip
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

Review 3.  Cell-derived microparticles in stored blood products: innocent-bystanders or effective mediators of post-transfusion reactions?

Authors:  Anastasios Kriebardis; Marianna Antonelou; Konstantinos Stamoulis; Issidora Papassideri
Journal:  Blood Transfus       Date:  2012-05       Impact factor: 3.443

4.  Pathologic mechanical stress and endotoxin exposure increases lung endothelial microparticle shedding.

Authors:  Eleftheria Letsiou; Saad Sammani; Wei Zhang; Tong Zhou; Hector Quijada; Liliana Moreno-Vinasco; Steven M Dudek; Joe G N Garcia
Journal:  Am J Respir Cell Mol Biol       Date:  2015-02       Impact factor: 6.914

5.  Cytoskeletal reorganization of human platelets induced by the protein phosphatase 1/2 A inhibitors okadaic acid and calyculin A.

Authors:  Y Yano; M Sakon; J Kambayashi; T Kawasaki; T Senda; K Tanaka; F Yamada; N Shibata
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

6.  Coagulation property of hyaluronic acid-collagen/chitosan complex film.

Authors:  Yangzhe Wu; Yi Hu; Jiye Cai; Shuyuan Ma; Xiaoping Wang
Journal:  J Mater Sci Mater Med       Date:  2008-07-19       Impact factor: 3.896

7.  Differential stimulation of monocytic cells results in distinct populations of microparticles.

Authors:  M Bernimoulin; E K Waters; M Foy; B M Steele; M Sullivan; H Falet; M T Walsh; N Barteneva; J-G Geng; J H Hartwig; P B Maguire; D D Wagner
Journal:  J Thromb Haemost       Date:  2009-06       Impact factor: 5.824

8.  Microvesicle release is associated with extensive protein tyrosine dephosphorylation in platelets stimulated by A23187 or a mixture of thrombin and collagen.

Authors:  J M Pasquet; J Dachary-Prigent; A T Nurden
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

9.  Incorporation of ophiobolin a into novel chemoembolization particles for cancer cell treatment.

Authors:  Rachel Morrison; Chris Gardiner; Antonio Evidente; Robert Kiss; Helen Townley
Journal:  Pharm Res       Date:  2014-05-03       Impact factor: 4.200

Review 10.  Characterizing blood microparticles: technical aspects and challenges.

Authors:  Arun S Shet
Journal:  Vasc Health Risk Manag       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.